Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 525 of 1715 entries
View as:
Phase: N/A
Priority: Normal
Start: 09/14/15
End: 03/31/17
Due: 03/31/18
Phase: N/A
Priority: Normal
Start: 05/31/13
End: 01/31/16
Due: 01/31/17
Phase: N/A
Priority: Normal
Start: 04/15/16
End: 04/15/22
Due: 04/15/23
Phase: N/A
Priority: Normal
Start: 05/18/22
End: 02/28/23
Due: 02/28/24
Phase: N/A
Priority: Normal
Start: 06/15/20
End: 02/15/21
Due: 02/15/22
Phase: N/A
Priority: Normal
Start: 09/02/19
End: 11/15/23
Due: 11/15/24
Phase: N/A
Priority: Normal
Start: 04/26/21
End: 12/21/21
Due: 12/21/22
Phase: N/A
Priority: Normal
Start: 04/11/22
End: 01/23/24
Due: 01/23/25
Phase: N/A
Priority: Normal
Start: 02/28/21
End: 04/30/22
Due: 04/30/23
Phase: N/A
Priority: Normal
Start: 04/23/15
End: 04/30/18
Due: 04/30/19
Phase: N/A
Priority: Normal
Start: 04/01/19
End: 12/01/21
Due: 12/01/22
Phase: N/A
Priority: Normal
Start: 08/01/25
End: 02/01/27
Due: 02/01/28
Phase: N/A
Priority: Normal
Start: 04/30/11
End: 05/31/17
Due: 05/31/18
Evaluation of Obstetrical and Neonatal Complications in Hereditary Haemorrhagic Telangiectasia (HHT)
Phase: N/A
Priority: Normal
Start: 10/02/18
End: 10/02/19
Due: 10/02/20
Phase: N/A
Priority: Normal
Start: 04/30/05
End: 06/30/08
Due: 06/30/09
Phase: N/A
Priority: Normal
Start: 09/20/10
End: 05/31/25
Due: 05/31/26
Phase: N/A
Priority: Normal
Start: 09/26/18
End: 07/30/19
Due: 07/30/20
Phase: N/A
Priority: Normal
Start: 03/31/25
End: 03/31/28
Due: 03/31/29
Phase: N/A
Priority: Normal
Start: 12/19/13
End: 12/19/17
Due: 12/19/18
Phase: N/A
Priority: Normal
Start: 07/01/23
End: 06/01/24
Due: 06/01/25
Phase: N/A
Priority: Normal
Start: 02/28/11
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 03/31/15
End: 01/31/20
Due: 01/31/21
Phase: N/A
Priority: Normal
Start: 03/13/18
End: 05/19/18
Due: 05/19/19
Phase: N/A
Priority: Normal
Start: 09/01/25
End: 11/01/28
Due: 11/01/29
Phase: N/A
Priority: Normal
Start: 10/31/14
End: 02/29/16
Due: 02/28/17